Skip to main content
. 2022 Jan 20;22:85. doi: 10.1186/s12885-021-09160-1

Table 2.

Summary of somatic variants in sequenced samples

Sample* Number of somatic SNVs Number of Mutations/
Mb
Annotation of Somatic SNVs Number of shared somatic SNVs % of shared SNVs
Exonic Intronic
Total Non-synonymous
1084_P0 4056 1.35 37 25 854 228 5.6%
1084_T0 6070 2.02 77 59 1950 3.8%
1249_P0 4142 1.38 39 27 897 387 9.3%
1249_T0 1120 0.37 13 10 288 34.6%
1494_P0 3433 1.14 22 11 783 262 7.6%
1494_T0 1271 0.42 18 11 392 20.6%
1524_P0 4771 1.59 39 23 1090 281 5.9%
1524_T0 2841 0.95 37 23 840 9.9%
065_P0 3857 1.29 38 24 897
098_P0 5637 1.88 47 28 1356

* T0 tumour, P0 plasma, * Patients with breast cancer - 1084, 1249, 1494 and 1524; patients with benign tumours - 065 and 098